BIOMAT Database Logo BIOMAT Database Logo

Selective Serotonin Reuptake Inhibitors. 2019

Dee Lochmann, and Tara Richardson
Psychiatry and Behavioral Sciences, University of Kansas School of Medicine-Wichita, Wichita, KS, USA. dlochmann@kumc.edu.

The first antidepressants were created by chance but brought the idea that central serotonin agonism produced an antidepressant effect. SSRIs were the first class of psychotropic medications to be rationally designed, meaning that researchers intended to utilize a specific mechanism of action while avoiding adverse effects. In this way, SSRIs were created to be safer and more tolerable than previous antidepressants. SSRIs share many similarities, but differ in terms of pharmacokinetics and effects on CYP450 enzymes, which is detailed in this chapter. Further information will be provided regarding safety, clinical indications/uses, and dosing recommendations.

UI MeSH Term Description Entries
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D017367 Selective Serotonin Reuptake Inhibitors Compounds that specifically inhibit the reuptake of serotonin in the brain. 5-HT Uptake Inhibitor,5-HT Uptake Inhibitors,5-Hydroxytryptamine Uptake Inhibitor,5-Hydroxytryptamine Uptake Inhibitors,SSRIs,Selective Serotonin Reuptake Inhibitor,Serotonin Reuptake Inhibitor,Serotonin Reuptake Inhibitors,Serotonin Uptake Inhibitor,Serotonin Uptake Inhibitors,Inhibitors, 5-HT Uptake,Inhibitors, 5-Hydroxytryptamine Uptake,Inhibitors, Serotonin Reuptake,Inhibitors, Serotonin Uptake,Reuptake Inhibitors, Serotonin,Uptake Inhibitors, 5-HT,Uptake Inhibitors, 5-Hydroxytryptamine,Uptake Inhibitors, Serotonin,Inhibitor, 5-HT Uptake,Inhibitor, 5-Hydroxytryptamine Uptake,Inhibitor, Serotonin Reuptake,Inhibitor, Serotonin Uptake,Reuptake Inhibitor, Serotonin,Uptake Inhibitor, 5-HT,Uptake Inhibitor, 5-Hydroxytryptamine,Uptake Inhibitor, Serotonin

Related Publications

Dee Lochmann, and Tara Richardson
Selective serotonin reuptake inhibitors.
June 1992, BMJ (Clinical research ed.),
Dee Lochmann, and Tara Richardson
Selective serotonin reuptake inhibitors.
October 2004, BMJ (Clinical research ed.),
Dee Lochmann, and Tara Richardson
Selective serotonin reuptake inhibitors.
January 1997, The Lippincott health promotion letter,
Dee Lochmann, and Tara Richardson
Selective serotonin reuptake inhibitors.
August 1992, BMJ (Clinical research ed.),
Dee Lochmann, and Tara Richardson
Selective serotonin reuptake inhibitors.
August 1992, BMJ (Clinical research ed.),
Dee Lochmann, and Tara Richardson
Selective serotonin reuptake inhibitors.
March 1998, Anaesthesia,
Dee Lochmann, and Tara Richardson
Selective serotonin reuptake inhibitors.
October 1992, BMJ (Clinical research ed.),
Dee Lochmann, and Tara Richardson
Selective serotonin reuptake inhibitors pathway.
November 2009, Pharmacogenetics and genomics,
Dee Lochmann, and Tara Richardson
Selective serotonin reuptake inhibitors prescriptions.
July 1996, The New Zealand medical journal,
Dee Lochmann, and Tara Richardson
Selective serotonin reuptake inhibitors in OCD.
January 1992, Clinical neuropharmacology,
Copied contents to your clipboard!